Ceftazidime 2 g/Avibactam 0.5 g Injection

Article Sidebar

PDF
Published: Apr 28, 2023
Keywords:
ceftazidime beta-lactam antibiotics avibactam beta-lactamase inhibitor รักษาการติดเชื้อ complicated intra-abdominal infection

Main Article Content

Jantarika Sanankiatcharoen
Department of Pharmacy, Prapokklao Hospital, Chantaburi Province

Abstract

          Ceftazidime 2 g /avibactam 0.5 g injection is cephalosporin combination, ceftazidime is semisynthetic cephalosporin and avibactam is beta-lactamase inhibitor. Ceftazidime /avibactam is indicated for the treatment of complicated intra-abdominal Infection, complicated urinary tract infection, hospital-acquired pneumonia including ventilator-associated pneumonia and pyelonephritis. Ceftazidime/avibactam is an effective therapy for severe infections including carbapenem resistant Enterobacteriaceae (CRE).

Article Details

Issue
Vol. 40 No. 2 (2023): April - June
Section
Interesting Drugs
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

Lagacé-Wiens P, Walkty A,Karlowsky JA. Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infec tions. Core Evid 2014;9:13-25.

Lacy C, Armstrong L, Goldman M, Lance L. Drug information handbook with International Trade Names Index. 26 th ed. North America: Lexi-Comp Inc; 2017.

Medscape. Ceftazidime/avibactam. [Internet]. 2022 [cited 2022 Jul 10]. Available from:https://reference.medscape.com/drug/avycaz ceftazidime-avibactam-999985#0

Gray A, Wright J, Goodey V, Bruce L.Injectable Drugs Guide. London: Pharmaceutical Press; 2011.

National Drug Information. Zaviceftatm (avibactam sodium, ceftazidime pentahydrate) [In-ternet]. Nonthaburi: Food and Drug Administration; 2017 [cited 2022 Jul 10]. Available from: http://ndi.fda.moph.go.th/uploads/drug_detail_corporation/doc/word/1163/9cf8708e8acfa4e13c8a194beeb8d80d-a1.pdf

Alraddadi BM, Saeedi M, Qutub M, Alshukairi A, Hassanien A, Wali G. Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae. BMC Infect Dis [Internet]. 2019.[cited 2022 Sep 29];19: 772 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724371/

Balandín B, Ballesteros D, Pintado V, Soriano-Cuesta C, Cid-Tovar I, Sancho-González M, et al. Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in criti-cally ill patients. Int J Antimicrob Agents [Internet]. 2022 [cited 2022 Sep 29];59(3): 106536. Available from: https://www.sciencedirect.com/science/article/pii/S0924857922000267?via%3Dihub